This page includes the latest FDA filings for Enzo Biochem Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
USA | NEW YORK STOCK EXCHANGE | ENZ | DUNS 081664328 |
Device Company | Device | Date |
---|---|---|
ENZO BIOCHEM, INC. | COLORGENE HSV DNA HYBRIDIZATION TEST | 1988-08-03 |
ENZO BIOCHEM, INC. | HEMAGEL(TM) TEST FOR FECAL OCCULT BLOOD | 1988-07-08 |
ENZO BIOCHEM, INC. | COLORGENE FLUORESCENT DNA HYBRIDIZATION TEST / CMV | 1988-03-28 |
ENZO BIOCHEM, INC. | COLORGENE DNA HYBRIDIZATION TEST CMV CONFIRMATION | 1987-12-04 |
ENZO BIOCHEM, INC. | COLORGENE DNA HYBRIDIZATION TEST FOR HSV CONFIRMA. | 1987-05-26 |
NCAGE Code | 0B113 | ENZO BIOCHEM INC |
NCAGE Code | 84DV4 | ENZO BIOCHEM, INC. |
CAGE Code | 0B113 | ENZO BIOCHEM INC |
CAGE Code | 4CDQ3 | ENZO BIOCHEM, INC. ENZO THERAPEUTICS INC |
CAGE Code | 84DV4 | ENZO BIOCHEM, INC. |
S.A.M. Registration | 84DV4 [809381247] | ENZO BIOCHEM, INC. |
SEC | 0000316253 | ENZO BIOCHEM INC of NEW YORK |